|
"hsiao cf"的相關文件
顯示項目 21-45 / 201 (共9頁)
1 2 3 4 5 6 7 8 9 > >>
每頁顯示[10|25|50]項目
| 國家衛生研究院 |
2021-09-27 |
Comment on"Biostatistical considerations when using RWD and RWE in clinical studies for regulatory purposes: A landscape assessment": Is real-world evidence real?
|
Chen, C;Hsiao, CF |
| 國家衛生研究院 |
2021-09 |
A phase II trial of nivolumab and gemcitabine and S-1 as the first-line treatment in patients with advanced biliary tract cancer
|
Chiang, NJ;Bai, LY;Huang, CJ;Chen, SC;Hsiao, CF;Shan, YS;Su, YY;Chen, L;Chen, MH |
| 國家衛生研究院 |
2021-05 |
High expression of krüppel-like factor 10 or Smad4 predicts clinical benefit of adjuvant chemoradiotherapy in curatively resected pancreatic adenocarcinoma: From a randomized phase III trial
|
Pen, SL;Shan, YS;Hsiao, CF;Liu, TW;Chen, JS;Ho, CL;Chou, WC;Hsieh, RK;Chen, LT;Ch'ang, HJ |
| 國家衛生研究院 |
2021-05 |
A phase 2 study of liposomal irinotecan with 5-fluorouracil and leucovorin in squamous cell carcinoma of head and neck or esophagus after prior platinum-based chemotherapy or chemoradiotherapy
|
Bai, LY;Yang, MH;Chiang, NJ;Wu, SY;Lin, CY;Lien, MY;Chen, JH;Chang, MH;Hsieh, CY;Hong, RL;Kao, HF;Ye, RH;Chen, SH;Hsiao, CF;Chen, LT;Liu, TW |
| 國家衛生研究院 |
2021-05 |
TCOG T5217 trial: A phase II randomized study of SLOG versus modified FOLFIRINOX as the first-line treatment in locally advanced or metastatic pancreatic ductal adenocarcinoma
|
Chiang, NJ;Shan, YS;Bai, LY;Li, CP;Chen, JS;Yang, SH;Kuo, YC;Chao, Y;Hsieh, YY;Kao, HF;Hsiao, CF;Chen, LT |
| 國家衛生研究院 |
2021-02-05 |
Tolerance interval testing for assessing accuracy and precision simultaneously
|
Chiang, C;Hsiao, CF |
| 中山醫學大學 |
2021 |
Sub-multiplicative interaction between polygenic risk score and household coal use in relation to lung adenocarcinoma among never-smoking women in Asia
|
Blechter, B; Wong, JYY; Hsiung, CA; Hosgood, HD; Yin, ZH; Shu, XO; Zhang, H; Shi, JX; Song, L; Song, MS; Zheng, W; Wang, ZM; Caporaso, N; Burdette, L; Yeager, M; Berndt, SI; Landi, MT; Chen, CJ; Chang, GC; Hsiao, CF; Tsai, YH; Chen, KY; Huang, MS; Su, WC; Chen, YM; Chien, LH; Chen, CH; Yang, TY; Wang, CL; Hung, JY; Lin, CC; Perng, RP; Chen, CY; Chen, KC; Li, YJ; Yu, CJ; Chen, YS; Chen, YH; Tsai, FY; Seow, WJ; Bassig, BA; Hu, W; Ji, BT; Wu, W; Guan, P; He, QC; Gao, YT; Cai, QY; Chow, WH; Xiang, YB; Lin, DX; Wu, C; Wu, YL; Shin, MH; Hong, YC; Matsuo, K; Chen, KX; Wong, MP; Lu, DR; Jin, L; Wang, JC; Seow, A; Wu, TC; Shen, HB; Fraumeni, JF; Yang, PC; Chang, IS; Zhou, BS; Chanock, SJ; Rothman, N; Chatterjee, N; Lan, Q |
| 國家衛生研究院 |
2020-12-29 |
Sub-multiplicative interaction between polygenic risk score and household coal use in relation to lung adenocarcinoma among never-smoking women in Asia
|
Blechter, B;Wong, JYY;Agnes Hsiung, C;Hosgood, HD;Yin, Z;Shu, XO;Zhang, H;Shi, J;Song, L;Song, M;Zheng, W;Wang, Z;Caporaso, N;Burdette, L;Yeager, M;Berndt, SI;Teresa Landi, M;Chen, CJ;Chang, GC;Hsiao, CF;Tsai, YH;Chen, KY;Huang, MS;Su, WC;Chen, YM;Chien, LH;Chen, CH;Yang, TY;Wang, CL;Hung, JY;Lin, CC;Perng, RP;Chen, CY;Chen, KC;Li, YJ;Yu, CJ;Chen, YS;Chen, YH;Tsai, FY;Jie Seow, W;Bassig, BA;Hu, W;Ji, BT;Wu, W;Guan, P;He, Q;Gao, YT;Cai, Q;Chow, WH;Xiang, YB;Lin, D;Wu, C;Wu, YL;Shin, MH;Hong, YC;Matsuo, K;Chen, K;Pik Wong, M;Lu, D;Jin, L;Wang, JC;Seow, A;Wu, T;Shen, H;Fraumeni, JF;Yang, PC;Chang, IS;Zhou, B;Chanock, SJ;Rothman, N;Chatterjee, N;Lan, Q |
| 國家衛生研究院 |
2020-12-09 |
On selecting the critical boundary functions in group-sequential trials with two time-to-event outcomes
|
Hamasaki, T;Hung, HMJ;Hsiao, CF;Evans, SR |
| 國家衛生研究院 |
2020-12-02 |
A multicenter, randomized, open-label, controlled trial to evaluate the efficacy and tolerability of hydroxychloroquine and a retrospective study in adult patients with mild to moderate coronavirus disease 2019 (COVID-19)
|
Chen, CP;Lin, YC;Chen, TC;Tseng, TY;Wong, HL;Kuo, CY;Lin, WP;Huang, SR;Wang, WY;Liao, JH;Liao, CS;Hung, YP;Lin, TH;Chang, TY;Hsiao, CF;Huang, YW;Chung, WS;Cheng, CY;Cheng, SH |
| 國家衛生研究院 |
2020-09-01 |
Use of a two-sided tolerance interval in the design and evaluation of biosimilarity in clinical studies
|
Chiang, C;Chen, CT;Hsiao, CF |
| 國家衛生研究院 |
2020-08-18 |
Operational experiences in China and statistical issues on the conduct of clinical trials during the COVID-19 pandemic
|
Guo, T;Chen, C;Chiang, C;Chen, CT;Hsiao, CF |
| 國家衛生研究院 |
2020-08-04 |
Use of tolerance intervals for assessing biosimilarity
|
Chen, C;Hsiao, CF |
| 國家衛生研究院 |
2020-05-12 |
Use of a tolerance interval approach as a statistical quality control tool for traditional Chinese medicine
|
Chiang, C;Lai, YH;Huang, BH;Guo, WJ;Wu, YJ;Chang, LC;Hsiao, CF |
| 國家衛生研究院 |
2020-04-21 |
Impact of cooking oil fume exposure and fume extractor use on lung cancer risk in non-smoking Han Chinese women
|
Chen, TY;Fang, YH;Chen, HL;Chang, CH;Huang, H;Chen, YS;Liao, KM;Wu, HY;Chang, GC;Tsai, YH;Wang, CL;Chen, YM;Huang, MS;Su, WC;Yang, PC;Chen, CJ;Hsiao, CF;Hsiung, CA |
| 國家衛生研究院 |
2020-01 |
A multicenter, phase I/II trial of biweekly S-1, leucovorin, oxaliplatin and gemcitabine in metastatic pancreatic adenocarcinoma–TCOG T1211 study
|
Chiang, NJ;Tsai, KK;Hsiao, CF;Yang, SH;Hsiao, HH;Shen, WC;Hsu, C;Lin, YL;Chen, JS;Shan, YS;Chen, LT |
| 中山醫學大學 |
2020 |
A multicenter, randomized, open-label, controlled trial to evaluate the efficacy and tolerability of hydroxychloroquine and a retrospective study in adult patients with mild to moderate coronavirus disease 2019 (COVID-19)
|
Chen, CP; Lin, YC; Chen, TC; Tseng, TY; Wong, HL; Kuo, CY; Lin, WP; Huang, SR; Wang, WY; Liao, JH; Liao, CS; Hung, YP; Lin, TH; Chang, TY; Hsiao, CF; Huang, YW; Chung, WS; Cheng, CY; Cheng, SH |
| 中山醫學大學 |
2020 |
Predicting Lung Cancer Occurrence in Never-Smoking Females in Asia: TNSF-SQ, a Prediction Model
|
Chien, LH; Chen, CH; Chen, TY; Chang, GC; Tsai, YH; Hsiao, CF; Chen, KY; Su, WC; Wang, WC; Huang, MS; Chen, YM; Chen, CY; Liang, SK; Chen, CY; Wang, CL; Lee, MH; Chung, RH; Tsai, FY; Hu, JW; Katki, HA; Chatterjee, N; Chanock, SJ; Rothman, N; Lan, Q; Yang, PC; Chen, CJ; Chang, IS; Hsiung, CA |
| 中山醫學大學 |
2020 |
Tuberculosis infection and lung adenocarcinoma: Mendelian randomization and pathway analysis of genome-wide association study data from never-smoking Asian women
|
Wong, JYY; Zhang, H; Hsiung, CA; Shiraishi, K; Yu, K; Matsuo, K; Wong, MP; Hong, YC; Wang, JC; Seow, WJ; Wang, ZM; Song, MS; Kim, HN; Chang, IS; Chatterjee, N; Hu, W; Wu, C; Mitsudomi, T; Zheng, W; Kim, JH; Seow, A; Caporaso, NE; Shin, MH; Chung, LP; An, SJ; Wang, P; Yang, Y; Zheng, H; Yatabe, Y; Zhang, XC; Kim, YT; Cai, QY; Yin, ZH; Kim, YC; Bassig, BA; Chang, J; Ho, JCN; Ji, BT; Daigo, Y; Ito, H; Momozawa, Y; Ashikawa, K; Kamatani, Y; Honda, T; Hosgood, HD; Sakamoto, H; Kunitoh, H; Tsuta, K; Watanabe, SI; Kubo, M; Miyagi, Y; Nakayama, H; Matsumoto, S; Tsuboi, M; Goto, K; Shi, JX; Song, L; Hua, X; Takahashi, A; Goto, A; Minamiya, Y; Shimizu, K; Tanaka, K; Wei, F; Matsuda, F; Su, J; Kim, YH; Oh, IJ; Song, FJ; Su, WC; Chen, YM; Chang, GC; Chen, KY; Huang, MS; Chien, LH; Xiang, YB; Park, JY; Kweon, SS; Chen, CJ; Lee, KM; Blechter, B; Li, HX; Gao, YT; Qian, BY; Lu, DR; Liu, JJ; Jeon, HS; Hsiao, CF; Sung, JS; Tsai, YH; Jung, YJ; Guo, H; Hu, ZB; Wang, WC; Chung, CC; Burdett, L; Yeager, M; Hutchinson, A; Berndt, SI; Wu, W; Pang, H; Li, YQ; Choi, JE; Park, KH; Sung, SW; Liu, L; Kang, CH; Zhu, M; Chen, CH; Yang, TY; Xu, J; Guan, P; Tan, W; Wang, CL; Hsin, M; Sit, KY; Chen, Y; Choi, YY; Hung, JY; Kim, JS; Il Yoon, H; Lin, CC; Park, IK; Xu, P; Wang, Y; He, Q; Perng, RP; Chen, CY; Vermeulen, R; Wu, JJ; Lim, WY; Chen, KC; Li, YJ; Li, JH; Chen, HY; Yu, CJ; Jin, L; Chen, TY; Jiang, SS; Liu, J; Yamaji, T; Hicks, B; Wyatt, K; Li, SA; Dai, JC; Ma, HX; Jin, GF; Song, B; Wang, ZH; Cheng, SS; Li, XL; Ren, YW; Cui, P; Iwasaki, M; Shimazu, T; Tsugane, S; Zhu, JJ; Yang, KY; Jiang, GN; Fei, K; Wu, GP; Lin, HC; Chen, HL; Fang, YH; Tsai, FY; Hsieh, WS; Yu, JM; Stevens, VL; Laird-Offringa, IA; Marconett, CN; Rieswijk, L; Chao, A; Yang, PC; Shu, XO; Wu, T; Wu, YL; Lin, DX; Chen, KX; Zhou, BS; Huang, YC; Kohno, T; Shen, H; Chanock, SJ; Rothman, N; Lan, Q |
| 國家衛生研究院 |
2019-12-18 |
An open-label, single-arm, two-stage, multicenter, phase II study to evaluate the efficacy of TLC388 and genomic analysis for poorly differentiated neuroendocrine carcinomas
|
Chen, MH;Chou, WC;Hsiao, CF;Jiang, SS;Tsai, HJ;Liu, YC;Hsu, C;Shan, YS;Hung, YP;Hsich, CH;Chiu, CH;Liu, TC;Cho, SF;Liu, TW;Chao, Y |
| 國家衛生研究院 |
2019-12-17 |
Predicting lung cancer occurrence in never-smoking females in Asia: TNSF-SQ, a prediction model
|
Chien, LH;Chen, CH;Chen, TY;Chang, GC;Tsai, YH;Hsiao, CF;Chen, KY;Su, WC;Wang, WC;Huang, MS;Chen, YM;Chen, CY;Liang, SK;Chen, CY;Wang, CL;Lee, MH;Chung, RH;Tsai, FY;Hu, JW;Katki, HA;Chatterjee, N;Chanock, SJ;Rothman, N;Lan, Q;Yang, PC;Chen, CJ;Chang, IS;Hsiung, CA |
| 國家衛生研究院 |
2019-11-14 |
A multicenter prospective study of first-line antibiotic therapy for early-stage gastric mucosa-associated lymphoid tissue lymphoma and diffuse large B-cell lymphoma with histological evidence of mucosa-associated lymphoid tissue
|
Tsai, HJ;Tai, JJ;Chen, LT;Wu, MS;Yeh, KH;Lin, CW;Wang, TE;Wang, HP;Yu, FJ;Liou, JM;Hsiao, CF;Cheng, TY;Yeh, HJ;Ko, CW;Chen, MJ;Lo, GH;Hsu, PI;Chang, CS;Hwang, WS;Chuang, SS;Lee, HW;Shun, CT;Chiu, CF;Wang, WM;Hsieh, CY;Liu, TW;Lin, JT;Kuo, SH;Cheng, AL |
| 國家衛生研究院 |
2019-07-12 |
Tuberculosis infection and lung adenocarcinoma: Mendelian randomization and pathway analysis of genome-wide association study data from never-smoking Asian women
|
Wong, JYY;Zhang, H;Hsiung, CA;Shiraishi, K;Yu, K;Matsuo, K;Wong, MP;Hong, YC;Wang, J;Seow, WJ;Wang, Z;Song, M;Kim, HN;Chang, IS;Chatterjee, N;Hu, W;Wu, C;Mitsudomi, T;Zheng, W;Kim, JH;Seow, A;Caporaso, NE;Shin, MH;Chung, LP;An, SJ;Wang, P;Yang, Y;Zheng, H;Yatabe, Y;Zhang, XC;Kim, YT;Cai, Q;Yin, Z;Kim, YC;Bassig, BA;Chang, J;Ho, JCM;Ji, BT;Daigo, Y;Ito, H;Momozawa, Y;Ashikawa, K;Kamatani, Y;Honda, T;Hosgood, HD;Sakamoto, H;Kunitoh, H;Tsuta, K;Watanabe, SI;Kubo, M;Miyagi, Y;Nakayama, H;Matsumoto, S;Tsuboi, M;Goto, K;Shi, J;Song, L;Hua, X;Takahashi, A;Goto, A;Minamiya, Y;Shimizu, K;Tanaka, K;Wei, F;Matsuda, F;Su, J;Kim, YH;Oh, IJ;Song, F;Su, WC;Chen, YM;Chang, GC;Chen, KY;Huang, MS;Chien, LH;Xiang, YB;Park, JY;Kweon, SS;Chen, CJ;Lee, KM;Blechter, B;Li, H;Gao, YT;Qian, B;Lu, D;Liu, J;Jeon, HS;Hsiao, CF;Sung, JS;Tsai, YH;Jung, YJ;Guo, H;Hu, Z;Wang, WC;Chung, CC;Burdett, L;Yeager, M;Hutchinson, A;Berndt, SI;Wu, W, .;et al. |
| 國家衛生研究院 |
2019-06-21 |
Cost-effectiveness of preventing hepatitis B virus reactivation in patients with lymphoma and resolved HBV infection
|
Tsou, HH;Yang, HC;Hsiao, CF;Hsiung, CA;Liu, TW;Chuang, MH;Wu, HY;Hsu, YT;Tsui, CW;Chen, PJ;Cheng, AL;Hsu, C; the Taiwan Cooperative Oncology Group |
| 國家衛生研究院 |
2019-05 |
An open label, single-arm, two-stage, multicenter, phase II study to evaluate the efficacy and safety of TLC388 as second-line treatment in subjects with poorly differentiated neuroendocrine carcinomas (TCOGT1Z14)
|
Chen, MH;Chou, WC;Hsiao, CF;Liu, YC;Hsu, C;Yanshen, S;Hung, YP;Hsieh, CH;Chiu, CH;Liu, TC;Cho, SF;Liu, TW;Chao, Y |
顯示項目 21-45 / 201 (共9頁)
1 2 3 4 5 6 7 8 9 > >>
每頁顯示[10|25|50]項目
|
